FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

GAMCO INVESTORS, INC. ET AL

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/27/2008 

3. Issuer Name and Ticker or Trading Symbol

LIFECORE BIOMEDICAL INC [LCBM]

(Last)        (First)        (Middle)

ONE CORPORATE CENTER, 

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

RYE, NY 10580       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   12000   I   By: Investment Partnership I   (1)
Common Stock   94183   I   By: Investment Partnership II   (1)
Common Stock   6000   I   By: Investment Partnership III   (1)
Common Stock   72762   I   By: Investment Partnership IV   (1)
Common Stock   85000   D   (2)  
Common Stock   9000   I   By: Investment Partnership V   (1)
Common Stock   8000   I   By: Investment Partnership VI   (1)
Common Stock   33000   I   By: Investment Partnership VII   (1)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  The Reporting Persons have less than a 100% interest in this entity. The amount of securities reported as beneficially owned reflects the total amount of securities held by this entity which is greater than the Reporting Persons indirect pecuniary interests. The Reporting Persons hereby disclaim ownership of these securities in excess of their pecuniary interests.
( 2)  These securities are owned by GAMCO Investors, Inc. ("GBL"). GGCP, Inc. and Mr. Mario J. Gabelli have less than a 100% interest in GBL and hereby disclaim ownership of these securities in excess of their pecuniary interests.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
GAMCO INVESTORS, INC. ET AL
ONE CORPORATE CENTER
RYE, NY 10580
X

GABELLI MARIO J
C/O GAMCO INVESTORS, INC.
ONE CORPORATE CENTER
RYE, NY 10580
X

GGCP, INC.
140 GREENWICH AVENUE
GREENWICH, CT 06830
X


Signatures
/s/ Peter D. Goldstein, Attorney-in-Fact for MARIO J. GABELLI, GGCP, INC., and GAMCO INVESTORS, INC. 3/6/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Lifecore Biomedical (MM) (NASDAQ:LCBM)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Lifecore Biomedical (MM) Charts.
Lifecore Biomedical (MM) (NASDAQ:LCBM)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Lifecore Biomedical (MM) Charts.